Aurous healthcare

Our Experiences

Clinical Trial Management

  • 2 Phase III trial on Dysmenorrhea
  • 2 Phase III trial for Osteoporosis
  • 2Phase III trial for Pressure Ulcer
  • 2 Phase III trial for Osteoarthritis
  • Observational trial for Cataract surgery
  • Phase IV trial on Mild to Moderate Hyper cholesterolemia
  • Phase IV dermatological trial on naturally derived coloring agents
  • 6 Phase IV trials on Herbal Cosmeceuticals

Medical Writing and Regulatory Affairs:

  • Prepared primary and secondary documents for nearly 25 clinical trials in internationally acceptable standards
  • Prepared clinical study report on Antibiotic drugs prepared protocol for seven trials including phase 2, 3, 4 and observational trials
  • Preparation of essential documents for a phase III trial
  • Prepared 35 regulatory dossiers to the developed and third world countries as per the respective regulatory agencies
  • Obtained DCGI notification for seven Phase III trials
  • Prepared PSUR for products Miochol, Moxifur, Apidine and Alfapres T
  • Experience in regulatory coordination in export of biologics

Clinical Data Management and statistical analysis:

  • Developed five phase 3 and two phase 4 clinical study designs. Prepared four clinical study reports for trials that have been conducted by AHC

Pre Clinical services:

Coordinated Pre Clinical studies on

  • Topical ophthalmic solution
  • Novel ophthalmic Fixed dose combination
  • General Anesthetics
  • 10 Herbal Medicines

Drug Development Services:

  • Novel Fixed Dose combination used as a Mydriatics in Ophthalmology

Medical consultancy services:

  • We have supported many clients to successfully make a molecule to reach the market
  • We have also dealt with identifying suitable pharmaceutical ingredient sources with international Drug Master Files and escalated the project to the stage of commercialization
  • We have gained laurels as envoy outsourcing partner for various global organizations
  • We endow medical consultancy with versatile client profiles

BA/BE services:

  • Coordinated and conducted many BA/BE studies

News

News

  • Article in The Hindu - BUSINESS LINE (March 10, 2014; Pg 18) detailing about R & D partnership of Aurous Healthcare for one of our primordial client- Dhathri Group Readmore..
  • “Article in Deccan Chronicle Chennai (04-Aug-13 Pg26) on the health benefits of Collagen Peptide by Dr. VT.Sriraam” Download Article

  • Public awareness article written by our Managing Director Dr. V. T. Sriraam, M.B.B.S, M.D. published in Tamil Daily "Thinathanthi" on 03-Feb-13. Download Article

  • We are awarded as “The most promising Healthcare R&D Company from Chennai, Tamil Nadu” by BIG research, a brand finding organization from Delhi with its media PartnerNDTV Profit.
    You tube Link: http://youtu.be/eMW1VeSzp2M

  • For the first time in the arena of Clinical Research Academy of India, our academic division “Auro Academy of Education and Research” launches a course in clinical research “Fellowship in Clinical Research Management” with 100% Job Guarantee (14 months work experience as CRA/CRC in our CRO).
    Link: http://auroushealthcare.com/pdf/AAER%20BROCHURE.pdf

  • We have set records in successful completion of two phase III trials on Osteoarthritis on collagen peptide, undertaken from an Indo Japan client and the product Gelixer has got launched successfully into the market
    Link: :http://www.gelixer.com/medical_professionals.asp http://www.youtube.com/watch?feature=player_embedded&v=YoybGsbsQno#!

  • Undertaking of a drug discovery and drug development – End to End project: We have successfully completed formulation and development and animal studies of a FDC (Fixed dose combination) project in Ophthalmology for an Indo MNC. Clinical trial is to be commenced shortly.

  • Ongoing clinical trial projects:
    • Phase III b trial on Osteoporosis
    • Phase III b trial on Dysmennorrhea
    • Dermatological trial on coloring agents
    • 6 Phase IV trials on herbal cosmeceuticals

  • We have completed a two animal toxicity study for FDC (fixed dose combination) in ophthalmology.

  • We have successfully completed the 2nd Surveillance Audit for ISO 9001:2015 certification for Quality Management System.

  • Our Medical Director, DR. V.T. Sriraam, M.D (Pharmacology), has presented a topic in 2011 International Conference on Food Factors on RCT to prove effectiveness and safety of Colla Pep JP and Colla Pep PU dated Nov 20-23, 2011, Taiwan.
    Link :http://www.icoff2011.org/SponsorSessionSpeakers.html

  • Presently, we are undertaking 12 end to end clinical trial managementing various therapeutic areas for Indian, Malaysian and Japanese based MNC.

Our Services

Embroidered Devil Eyes
Spring Embroidery
Geometrical Embroidery
Elephant with Luck
Lady in Red
Fireworks Embroidery Art
Fireworks Embroidery Art

Vision and Mission

Vision
To become the world’s premier quality driven organization in the field of clinical research..Readmore

News and Downloads

Article in Deccan Chronicle Chennai (04-Aug-13 Pg26) on the health benefits..Readmore

Accreditation

ISO Certificate
We have successfully completed the2nd Surveillance Audit for ISO 9001:2015Download

Corporate Brochure

No matter what the scope of the activity, our approach remains consistent. Quality Wins!..Download